PALIPERIDONE Spirig HC ret susp inj 25 mg/0.25ml
7680693560017
CH-69356
N05AX13
01.05.0.
Active substances:
1 / 3
google
Details
- Product number
- 6935601
- CPT
- -
- Packaging group
- 1
- Unit
- Fertigspritze(n)
- Composition
- paliperidonum 25 mg ut paliperidoni palmitas, polysorbatum 20 3 mg, macrogolum 4000, acidum citricum monohydricum, dinatrii phosphas, natrii dihydrogenophosphas monohydricus, natrii hydroxidum, aqua ad iniectabile ad suspensionem pro 0.25 ml corresp. natrium 0.92 mg.
Articles (1)
Paliperidon Spirig HC retard 25 mg/0.25 ml, Depot-Injektionssuspension in einer Fertigspritze
Injektionssuspension
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
paliperidonum
|
25.0 MG | Substance | Wirkstoff (Principe actif) |
|
paliperidoni palmitas
|
- | Substance | WIZUS |
|
polysorbatum 20
|
3.0 MG | Substance | HBESI |
|
macrogolum 4000
|
- | Substance | HNIDK |
|
acidum citricum monohydricum
|
- | Substance | HNIDK |
|
dinatrii phosphas
|
- | Substance | HNIDK |
|
natrii dihydrogenophosphas monohydricus
|
- | Substance | HNIDK |
|
natrii hydroxidum
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
natrium
|
0.92 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 91.10
Specialties list
Yes
Generic
Yes
SL addition date:
01/12/2024
Authorization holder
Spirig HealthCare AG
4622 Egerkingen
Authorization information
- Swissmedic authorization number
- 69356
- Drug name
- Paliperidon Spirig HC retard, Depot-Injektionssuspension in einer Fertigspritze
- Galenic form
- DEPISF
- ATC Code
- N05AX13
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 24/04/2024
- Authorization expiration date
- 23/04/2029
- IT number
- 01.05.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- PALIPERIDONE Spirig HC ret susp inj 25 mg/0.25ml
- Description (DE)
- PALIPERIDON Spirig HC ret Inj Susp 25 mg/0.25ml
- Market launch
- 24/04/2024
- Narcotic (BTM)
- No